SCHEMBL7534790

SCHEMBL7534790

CCC(COC)n1nnc2c(N(CC)c3c(C)cc(C)nc3C)nc(C)nc21

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7624865 0.88 CRHR1 (0.46) CRHR1
SCHEMBL7621616 0.86 CRHR1 (0.47) CRHR1
SCHEMBL20733330 0.80 CRHR1 (0.48) CRHR1
SCHEMBL7483912 0.77 CRHR1 (0.51) CRHR1
SCHEMBL8196088 0.76 CRHR1 (0.56) CRHR1
SCHEMBL22106778 0.74 CRHR1 (0.39) CRHR1
SCHEMBL20733328 0.73 CRHR1 (0.51) CRHR1
SCHEMBL7218557 0.71 CRHR1 (0.40) CRHR1
SCHEMBL8202018 0.69 CRHR1 (0.56) CRHR1
SCHEMBL21886232 0.69 CRHR1 (0.36) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448261-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-10 US disclosed
EP-0935601-A4 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARM CO (US) 2002-08-07 EP disclosed
EP-0935601-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES Du Pont Pharmaceuticals Company (US) 1999-08-18 EP disclosed
WO-1997035539-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-02 WO disclosed